Publication | Open Access
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
631
Citations
12
References
2012
Year
J-ROCKET AF demonstrated the safety of a Japan-specific rivaroxaban dose and supports bridging the global ROCKET AF results into Japanese clinical practice.
| Year | Citations | |
|---|---|---|
Page 1
Page 1